IGMS - IGM Biosciences Inc
IEX Last Trade
10.2
-0.110 -1.078%
Share volume: 75,483
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$10.31
-0.11
-1.07%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-03 | 2023-03-30 | 2023-05-12 | 2023-08-03 | 2023-11-13 | 2024-03-07 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 582.197 M | 540.936 M | 513.499 M | 462.742 M | 480.658 M | 474.350 M | 423.411 M | 376.132 M | |
| Current Assets | 521.835 M | 479.966 M | 438.421 M | 384.756 M | 401.760 M | 398.395 M | 347.597 M | 302.753 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.933 M | 10.134 M | 10.570 M | 10.702 M | 14.249 M | 10.787 M | 9.328 M | 8.660 M | |
| Short Term Investments | 7.933 M | 10.134 M | 10.570 M | 10.702 M | 14.249 M | 10.787 M | 9.328 M | 8.660 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 513.205 M | 469.139 M | 427.162 M | 373.396 M | 386.869 M | 386.991 M | 337.677 M | 293.768 M | |
| Total Non-current Assets | 60.362 M | 60.970 M | 75.078 M | 77.986 M | 78.898 M | 75.955 M | 75.814 M | 73.379 M | |
| Property Plant Equipment | 31.288 M | 31.886 M | 33.484 M | 36.731 M | 38.366 M | 36.879 M | 38.232 M | 37.300 M | |
| Other Assets | 29.074 M | 29.084 M | 41.594 M | 41.255 M | 40.532 M | 39.076 M | 37.582 M | 36.079 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 582.197 M | 540.936 M | 513.499 M | 462.742 M | 480.658 M | 474.350 M | 423.411 M | 376.132 M | |
| Total liabilities | 206.786 M | 212.761 M | 226.236 M | 223.312 M | 222.051 M | 220.488 M | 220.177 M | 214.879 M | |
| Total current liabilities | 35.817 M | 44.484 M | 44.685 M | 43.632 M | 44.299 M | 42.965 M | 42.481 M | 37.930 M | |
| Accounts Payable | 3.459 M | 2.731 M | 2.512 M | 3.972 M | 4.936 M | 3.913 M | 1.326 M | 3.995 M | |
| Other liabilities | 146.116 M | 144.546 M | 146.195 M | 144.812 M | 143.216 M | 142.539 M | 143.024 M | 142.649 M | |
| Current long term debt | 4.272 M | 4.349 M | 5.816 M | 6.426 M | 6.881 M | 6.206 M | 5.834 M | 6.628 M | |
| Long term debt | 24.853 M | 23.731 M | 35.356 M | 34.868 M | 34.536 M | 34.984 M | 34.672 M | 34.300 M | |
| Other liabilities | 146.116 M | 144.546 M | 146.195 M | 144.812 M | 143.216 M | 142.539 M | 143.024 M | 142.649 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 375.411 M | 328.175 M | 287.263 M | 239.430 M | 258.607 M | 253.862 M | 203.234 M | 161.253 M | |
| Common stock | 43.919 M | 44.035 M | 44.383 M | 44.467 M | 45.123 M | 59.580 M | 60.078 M | 60.114 M | |
| Retained earnings | -464.213 M | -522.250 M | -574.826 M | -634.135 M | -698.558 M | -760.547 M | -821.242 M | -871.058 M |